Hisgade (Suzhou) Biomedical Technology

Hisgade (Suzhou) Biomedical Technology

Medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Sep 2022.)
Suzhou Shi Jiangsu (HQ)
  • Edit
DateInvestorsAmountRound

CNY100m

Seed
*

CNY100m

Series A
*

N/A

Series B
Total Funding$27.5m

Recent News about Hisgade (Suzhou) Biomedical Technology

Edit